The following treatments were administered over a 7-day period: lornoxicam 8mg quick-release formulation or diclofenac potassium 50mg. On day 1, patients received in the clinic, no later than 2pm ...

The goal of the TIGHT K trial was to evaluate if prescribing relaxed control of potassium levels and only giving supplements in the rare event that levels became pathologically low was equally as ...

Objective: To compare the antipyretic and analgesic effects of a single oral dose of diclofenac potassium 6.25, 12.5 or 25mg with paracetamol 1000mg and placebo in patients with fever resulting ...